HALO logo
halo search icon
Eledon Pharmaceuticals, Inc.

US$3.84

Price Change Indicator
0.26 (7.26%)
Eledon Pharmaceuticals, Inc.
ELDN · NAS

Eledon Pharmaceuticals, Inc.

Start Trading ELDN for Free

US$3.84

Price Arrow0.26 (7.26%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Eledon Pharmaceuticals, Inc. Overview

ELDN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ELDN

icon
icon

Telephone

1.949.238.8090

icon

Address

Suite 250, 19800 MacArthur Boulevard, Irvine, CA 92612

Description

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

ELDN Price Chart

Key Stats

Market Cap

US$276.33M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.35 - 4.6

Trade Value (12mth)

US$865,565.00

1 week

-5.79%

1 month

-9.6%

YTD

120.99%

1 year

13.65%

All time high

4860.00

Key Fundamentals

EPS 3 yr Growth

-90.90%

EBITDA Margin

0.00%

Operating Cashflow

-$62m

Free Cash Flow Return

-48.70%

ROIC

-35.70%

Interest Coverage

0.00

Quick Ratio

7.40

Other Data

Shares Outstanding (Fully Diluted)

112m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ELDN Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

ELDN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-4.73-0.75-0.56locklocklock
EPS (Fully Diluted)
 $locklocklocklock-4.73-0.75-0.56locklocklock
Growth
 %locklocklocklock23.184.325.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Eledon Pharmaceuticals, Inc. (ELDN:NAS)?
Halo FAQ
The current share price of Eledon Pharmaceuticals, Inc. (ELDN:NAS) is USD$3.84.
What is the 52-week high share price for Eledon Pharmaceuticals, Inc. (ELDN:NAS)?
Halo FAQ
The 52-week high share price for Eledon Pharmaceuticals, Inc. (ELDN:NAS) is USD$4.60.
What is the 52-week low share price for Eledon Pharmaceuticals, Inc. (ELDN:NAS)?
Halo FAQ
The 52-week low share price for Eledon Pharmaceuticals, Inc. (ELDN:NAS) is USD$1.35.
What is the dividend yield for Eledon Pharmaceuticals, Inc. (ELDN:NAS)?
Halo FAQ
Eledon Pharmaceuticals, Inc. (ELDN:NAS) does not pay a dividend.
What was Eledon Pharmaceuticals, Inc. (ELDN:NAS) last dividend payment?
Halo FAQ
Eledon Pharmaceuticals, Inc. (ELDN:NAS) does not pay a dividend.
What is the franking level for Eledon Pharmaceuticals, Inc. (ELDN:NAS)?
Halo FAQ
Eledon Pharmaceuticals, Inc. (ELDN:NAS) has a franking level of 0.00%.
In which sector is Eledon Pharmaceuticals, Inc. (ELDN:NAS) classified?
Halo FAQ
Eledon Pharmaceuticals, Inc. (ELDN:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial